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We identified a case of fatal acute respiratory disease 
from household transmission of human adenovirus type 
55 (HAdV-55) in Anhui Province, China. Computed tomog-
raphy showed severe pneumonia. Comparative genomic 
analysis of HAdV-55 indicated the virus possibly originated 
in Shanxi Province, China. More attention should be paid to 
highly contagious HAdV-55.
Human adenoviruses are associated with mild and acute respiratory infections, depending on the vi-
rus type and host immunity. Human adenovirus type 55 
(HAdV-55) (1), formerly known as HAdV-11a (2), is a 
reemergent respiratory pathogen that has caused severe 
pneumonia outbreaks in military and civilian populations 
in Europe and Asia (2–7). However, household transmis-
sion of HAdV-55 is rarely reported. We report a case of 
household transmission of HAdV-55 involving 3 con-
firmed adult cases with 1 death. Epidemiologic, clinical, 
and laboratory investigations, along with whole-genome 
sequencing, elucidate the disease progression and the 
pathogen origin.
During April 1–May 5, 2012, 7 household members (5 
males and 2 females; 3 children and 4 adults) in Anhui Prov-
ince, China, sequentially experienced influenza-like symp-
toms, including fever, productive cough, fatigue, pharyngal-
gia, dyspnea, and other symptoms. The youngest patient was 
4 months of age, the oldest, whom we refer to as AQ-1, was 
a 55-year-old man. The family lived together near a farm in 
a house with poor sanitary and ventilation conditions. 
The first onset of acute respiratory disease (ARD) oc-
curred on April 1, when the index case, a 4-year-old grand-
daughter of AQ-1, had a febrile respiratory infection with 
cough. Three days later, AQ-1’s grandson, 1 year of age, 
displayed similar symptoms. On April 9 and 11, AQ-1’s 
daughter, 28 years of age, and another grandson, 4 months 
of age, both had influenza-like symptoms. On April 14, 
AQ-1 had a fever, chills, and lumbago. He was admitted to 
the hospital on April 14 where clinicians diagnosed pneu-
monia. AQ-1 had close contact with his sick grandsons and 
granddaughter and had not been out of the house during the 
month he cared for them. 
While hospitalized, AQ-1 had bilateral pneumonia 
seen on chest computed tomography (CT), a temperature of 
41.0°C, and low total leukocyte (3.63 × 109/L) and platelet 
(42 × 109/L) counts. AQ-1 sustained high fever and yellow 
phlegm despite antiinflammatory and antiviral treatment, 
including levofloxacin, piperacillin sodium, tazobactam so-
dium, and ribavirin. 
On April 24, AQ-1 had indications of severe pneumo-
nia, including respiratory failure, hypoxemia, double lung 
rales, and a mass of shadows visible on chest CT. In addi-
tion, he had indications of liver damage and multi-organ 
failure. Transverse chest CT images demonstrated in-
creased areas of patchy shadows and consolidation in both 
lungs compared to CT images from April 22, indicative of 
disease progression (Appendix Figure 1, http://wwwnc.
cdc.gov/EID/article/25/9/18-1937-App1.pdf).
AQ-1 died on April 27, 3 days after onset of respiratory 
failure, and 13 days after his illness began. On the same day, 
his 20-year-old son, AQ-2, and 31-year-old nephew, AQ-
3, who had taken care of AQ-1 for 5 days, also exhibited 
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symptoms of influenza-like illness. Both were hospitalized 
and had normal chest CT scans, but AQ-2’s leukocyte count 
was 5.4 × 109/L and AQ-3’s was 6.7 × 109/L. After antiin-
flammatory and antiviral treatment, including vitamin C, 
sulbactam, amoxicillin, amikacin, cefoperazone, ribavirin, 
and oseltamivir, they recovered and were discharged on 
May 5 (Figure). 
We tested endotracheal aspirates from AQ-1 and throat 
swabs from AQ-2 and AQ-3 for influenza A and B viruses, 
severe acute respiratory syndrome coronavirus, human 
metapneumovirus, rhinoviruses, parainfluenza viruses 
1–4, and HAdVs by real-time PCR. Only adenovirus was 
strongly positive for all 3 patients. Testing for antibodies 
against Mycoplasma pneumoniae, Mycobacterium tubercu-
losis Treponema pallidum, hepatitis B and C viruses, and 
HIV were all negative. After treatment, samples from AQ-2 
and AQ-3, were negative for adenovirus by PCR.
We isolated AQ-1’s adenovirus in culture and sequenced 
the genome (GenBank accession no. KP279748). Sequences 
for the hexon, penton base, and fiber genes were identical to 
those previously reported for HAdV-55. Phylogenetic analy-
sis showed that the 3 isolates clustered closely with other 
strains from China (Appendix Figure 2). The genome of 
AQ-1’s strain had the highest nucleotide identity (99.951%) 
with QZ01_2011, an isolate from a military trainee in Shanxi 
Province, China. The second highest identity (99.948%) was 
with QS-DLL_2006, which caused a fatal ARD outbreak in 
a senior high school in Shaanxi Province, China (1,8) (Ap-
pendix Table). We hypothesize the strain infecting AQ-1 and 
his family originated from Shanxi Province.
In this household transmission of ARD, the index case 
was a probable case because no specimens were collected 
to confirm virologic identification. From the timeline of ill-
ness onset in this household cluster of ARD cases (Figure), 
we suspect that the pathogen spread rapidly among the chil-
dren and further circulated in adults who had close contact 
with infected children and one another.
HAdV-55 contains a 97.4% genome of HAdV-14 and 
a hexon from HAdV-11 (1). Since 2006, HAdV-14 has 
caused severe ARD in America, Europe, and Asia (8,9), 
with high hospitalization (38%) and case-fatality (5%) 
rates (10). Because the risk for infection among the close 
contacts may rise, more attention should be paid to these 
highly contagious pathogens.
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Figure. Timeline of patients’ 
illness onset in a household 
cluster of acute respiratory 
disease from human 
adenovirus 55, Anhui Province, 
China, 2012. The star indicates 
AQ-1, the case described in 
this study. Case relationships to 
AQ-1 are indicated along with 
their ages at the date of their 
illness onset.
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Since 2012, Middle East respiratory syndrome (MERS) coro-
navirus has infected 2,442 persons worldwide. Case-based 
data analysis suggests that since 2016, as many as 1,465 
cases and 293–520 deaths might have been averted. Efforts 
to reduce the global MERS threat are working, but countries 
must maintain vigilance to prevent further infections.
From 2012 through May 31, 2019, Middle East respira-tory syndrome coronavirus (MERS-CoV) has infected 
2,442 persons and killed 842 worldwide (1). MERS-CoV 
is currently circulating in dromedary camels in Africa, the 
Middle East, and southern Asia; however, most cases of 
human infection have been reported in the Arabian Pen-
insula (2). Large hospital outbreaks in 2014 and 2015 
(3,4) (Appendix Figure 1, https://wwwnc.cdc.gov/EID/
article/25/9/19-0143-F1.htm) motivated affected countries 
to substantially invest in prevention and control activities. 
To estimate the potential number of MERS cases and 
deaths that might have been averted since 2016 had the risk 
levels of 2014–2015 continued, we analyzed case-based 
data on laboratory-confirmed human cases of MERS-CoV 
infections reported to the World Health Organization (5). 
We categorized cases as either secondary (human-to-human 
transmission) or community-acquired (presumed camel-to-
human transmission). In addition, we used case-based data 
on date of onset (for symptomatic infections) or report (for 
asymptomatic infections), outcome (died/recovered), and 
dates and sizes of reported clusters of human-to-human–
transmission cases (3,4,6–8).
We compared incidence of camel-to-human–transmis-
sion  cases (i.e., community-acquired cases, assuming all 
of those not positively attributed to human-to-human trans-
mission were in this category) during 2016, 2017, and 2018 
(through September only) with incidence during 2014–
2015, assuming that case numbers were Poisson distributed 
